HEM Pharma submits IND for phase 2a clinical trial of a new antidepressant candidate to the US FDA
2023.03.14
|
---|
Read more >>>> https://www.newspim.com/news/view/20230313000912 https://www.edaily.co.kr/news/read?newsId=03050406635542992&mediaCodeNo=257&OutLnkChk=Y https://newsis.com/view/?id=NISX20230313_0002224975&cID=10434&pID=13200
|